Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Remember what happen to the share price prior to the release of Phase 3 results.... it tanked. I loaded up in the 4’s.
Can we get this post pinned. Thanks
I own a medical device company (blood testing) where the CE took 7 months. May have a way to go yet.
My largest holding! Loving it!
Old news. Check Halo press release of March 2017. Complete overreaction.
https://finance.yahoo.com/news/halozyme-provides-swog-collaborative-group-123000120.html
Re Dr. KSS, nobody can be perfect in biotech, but I’m grateful to have him on my side!!
Should have a FDA decision by January 17, per Norchi.
Agree on stockgumshoe! Well worth it. Many well informed investors who willing to openly share their knowledge of biotech.
Nothing that we know of...though the company is positioning themselves to be bought out and J&J has the most to lose as they are the biggest player in the wound care market.
They may issue a PR about acceptance anytime, at least we shouldn't have to worry about a rejection!
Submitted on July 17. 15 calendar days = August 1. Don't they have 3 days to issue a negative? Past that?
Presentation in June, they said it's their intention to partner up. Hope they stay the course.
Lunacy, thank for sharing your DD! Gives me more confidence in my AUPH.
Agree it's almost time as the stock will react to the end of recruiting and trial results. Concerned about a stock offering. How soon before they raise funds?
If the Phase 3 for pain meets the trials endpoints, are we ready for an NDA? Or are more trials needed? Any idea?
Excellent DD. How do we pin this message?
CEO is on Mad Money tonight with Jim Cramer....can't hurt!
Priced @ 19.09, yesterday's closing price. Excellent pricing!
Have to agree. In 2016 Cynapsus was bought out months BEFORE the end of trials or any announcement of Phase 3 results. I had some but kept telling myself I would buy more as we get closer to results. My mistake, won't happen with this one.
There are a few of us here, but not many. Yahoo changed the format of their message boards and most posters went elsewhere. Not sure where. Let me know if you have any ideas.
Thoughts on how much of this move is optimism on the upcoming trial results and how much is a technical move?
I certainly hope so. I'm just suggesting that it is extremely risky to complete the Inspire Study and then submit both the Inspire Study results and the Cohort Study results and gamble that the FDA buys into this as a substitute for a control arm. Certainly they have a strong indication or possible approval. If not it could set them back by several quarters, meanwhile depleting their cash.
Thoughts on the "Cohort Study"? Results will be submitted with Inspire Study results. Surely the the FDA has approved this in place of the control group, otherwise it's a pretty big gamble to wait to the end. May mean control group issue has been resolved?
Although you never know, sounds like buyout will come in the second half of 2016!
Agreed...but neither will probably happen until at least mid-summer.
Gap up probably related to JNap's tweet that an Analyst & Investors Day is scheduled for December 3.
Awesome. Thanks Factman!
TD Ameritrade has my shares locked up as well. Wonder how long?
Help me out....why do you think the odds of a buyout in 2015 increased? Reverse split and uplist are good news, offering not so much.
My understanding is that doctors cannot mention the results of any past patients to future patients when discussing the surgery.
As a shareholder of NVIV, I too have done well, but it's well known NVIV has many catalysts to support their stock price. CYNAF needs to have something lined up prior to a r/s or the share price will drift lower. IMO
CYNAF working to get their name out in the investment community. Ad this past weekend in the National Post.
Holy shit, nice full page ad! $CYNAF / CTH.TO cc: @JNapodano pic.twitter.com/uopYWDAdgV
— CR 🎗🧡 (@CashRocket) March 24, 2015
Big week this week... Enrollment opens and more word on Jesi!
The CEO who has a significant stake in the company has made it clear from the very beginning that their intent is to sell the company at some point in the future. When is the question? He has also stated that based on other comparisons that he feels the company is worth $1 billion dollars! Hold on for and 8+ bagger!
JNap tweeted Analyst & Investors Day is March 18. Should hear about FDA meeting then.
True value of CYNAF can't be determined at this point until we know what % of that billion + market they get. However, they are ultimately worth what someone will pay for them.
True a buyout seems to be the intended course, but the CEO has stated his company is worth $1 Billion dollars. I believe that is an 8 bagger from here! And that buyout could easily come this year.